Table 3 Health impact assessment for PM2.5 (IHD by age).
Adults | Mortality; IHD for adults | Study year | |||||
|---|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | ||
25–29 years | Estimated Attributable Proportion | 41.1% (27.66–53.27%) | 41.35% (27.96–53.45%) | 36.2% (22.47–50.08%) | 39.58% (25.94–52.34%) | 39.13% (25.5-52.05%) | 41.83% )28.55–53.82%) |
Estimated number of Attributable Cases | 3 (2–4) | 2 (2–3) | 1 (0–1) | 2 (1–2) | 2 (1–2) | 2 (1–3) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 0.68 (0.46–0.88) | 0.67 (0.46–0.87) | 0.21 (0.13–0.29) | 0.49 (0.32–0.65) | 0.53 (0.34–0.70) | 0.76 (0.52–0.97) | |
RR (Lower-Upper) | 1.698 (1.382–2.14) | 1.705 (1.388–2.148) | 1.567 (1.289–2.003) | 1.655 (1.350–2.098) | 1.643 (1.342–2.086) | 1.719 (1.399–2.165) | |
30–34 years | Estimated Attributable Proportion | 39.06% (25.89–52.03%) | 39.3% (26.17–52.23%) | 34.27% (20.69–48.13%) | 37.57% (24.24–50.71%) | 37.13% (23.76–50.32%) | 39.77% (26.71–52.61%) |
Estimated number of Attributable Cases | 7(5–9) | 4 (3–6) | 4 (2–6) | 3 (2–5) | 6 (4–8) | 9 (6–12) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 1.97 (1.31–2.63) | 1.07 (0.71–1.42) | 1.01 (0.61–1.43) | 0.83 (0.54–1.12) | 1.39 (0.89–1.88) | 2.27 (1.52-3.00) | |
RR (Lower-Upper) | 1.641 (1.349–2.084) | 1.648 (1.354–2.093) | 1.521 (1.261–1.928) | 1.602 (1.320–2.029) | 1.591 (1.312–2.013) | 1.660 (1.365–2.110) | |
35–39 years | Estimated Attributable Proportion | 37.02% (25-48.48%) | 37.26% (25.26–48.68%) | 32.37% (19.92–44.41%) | 35.58% (23.35–47.27%) | 35.15% (22.89–46.91%) | 37.72% (25.74–49.07%) |
Estimated number of Attributable Cases | 7 (5–9) | 8 (5–10) | 6 (4–8) | 9 (6–12) | 8 (5–10) | 15 (10–19) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 2.56 (1.73–3.35) | 2.43 (1.65–3.18) | 1.82 (1.12–2.50) | 2.48 (1.63–3.30) | 2.06 (1.34–2.75) | 3.78 (2.58–4.92) | |
RR (Lower-Upper) | 1.588 (1.333–1.941) | 1.594 (1.338–1.949) | 1.479 (1.249–1.799) | 1.552 (1.305–1.896) | 1.542 (1.297–1.884) | 1.606 (1.347–1.963) | |
40–44 years | Estimated Attributable Proportion | 35.03% (22.63–46.45%) | 35.25% (22.87–46.63%) | 30.59% (17.98–42.5%) | 32.64% (21.1-45.15%) | 33.24% (20.66–44.83%) | 35.69% (23.35–46.95%) |
Estimated number of Attributable Cases | 11 (7–14) | 12 (8–15) | 11 (6–15) | 11 (7–15) | 10 (6–13) | 23 (15–30) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 4.80 (3.10–6.37) | 5.08 (3.29–6.71) | 4.45 (2.61–6.18) | 4.33 (2.71–5.80) | 3.63 (2.26–4.90) | 7.58 (4.96–9.97) | |
RR (Lower-Upper) | 1.539 (1.293–1.867) | 1.544 (1.297–1.874) | 1.441 (1.219–1.739) | 1.507 (1.267–1.823) | 1.498 (1.260–1.812) | 1.555 (1.305–1.885) | |
45–49 years | Estimated Attributable Proportion | 32.91% (22.39–43.02%) | 33.13% (22.62–43.19%) | 28.64% (18.23–39.62%) | 31.58% (21.06–42.08%) | 31.19% (20.7-41.77%) | 33.55% (23.07–43.52%) |
Estimated number of Attributable Cases | 12 (8–15) | 14 (10–18) | 15 (9–21) | 15 (10–20) | 15 (10–20) | 29 (20–37) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 6.49 (4.41–8.48) | 7.24 (4.94–9.44) | 7.64 (4.87–10.57) | 7.55 (5.03–10.06) | 7.31 (4.85–9.79) | 13.74 (9.45–17.82) | |
RR (Lower-Upper) | 1.491 (1.288–1.755) | 1.495 (1.292–1.760) | 1.401 (1.223–1.656) | 1.462 (1.267–1.726) | 1.453 (1.261–1.717) | 1.505 (1.2998-1.770) | |
50–54 years | Estimated Attributable Proportion | 30.69% (20.56–40.34%) | 30.89% (20.79–40.5%) | 26.7% (16.24–37.09%) | 29.44% (19.21–39.3%) | 29.08% (18.82–39.01%) | 31.29% (21.24–40.79%) |
Estimated number of Attributable Cases | 19 (13–25) | 23 (16–30) | 20 (12–27) | 17 (11–23) | 22 (14–29) | 26 (18–34) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 12.47 (8.36–16.40) | 15.01 (10.10-19.68) | 12.76 (7.77–17.73) | 10.57 (6.89–14.10) | 12.89 (8.34–17.29) | 14.84 (10.08–19.35) | |
RR (Lower-Upper) | 1.443 (1.259–1.676) | 1.447 (1.263–1.681) | 1.364 (1.194–1.589) | 1.417 (1.238–1.647) | 1.410 (1.232–1.6395) | 1.4554 (1.2697–1.689) | |
55–59 years | Estimated Attributable Proportion | 28.67% (18.62–37.65%) | 28.87% (18.85–37.81%) | 24.82% (14.65–34.16%) | 27.47% (17.35–36.6%) | 27.11% (16.98–36.29%) | 29.25% (19.3-38.12%) |
Estimated number of Attributable Cases | 21 (14–27) | 25 (17–33) | 27 (16–37) | 17 (11–23) | 29 (18–38) | 37 (25–49) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 18.05 (11.72–23.70) | 18.80 (12.28–24.62) | 19.96 (11.78–27.47) | 12.43 (7.85–16.56) | 20.68 (12.95–27.68) | 26.58 (17.54–34.65) | |
RR (Lower-Upper) | 1.402 (1.229–1.604) | 1.406 (1.232–1.608) | 1.330 (1.172–1.519) | 1.379 (1.210–1.577) | 1.372 (1.205–1.569) | 1.413 (1.239–1.616) | |
60–64 years | Estimated Attributable Proportion | 25.99% (16.52–34.31%) | 26.17% (16.7-34.46%) | 22.35% (13.09–31.11%) | 24.84% (15.34–33.36%) | 24.51% (15.01–33.06%) | 26.54% (17.06–34.77%) |
Estimated number of Attributable Cases | 21 (14–28) | 26 (17–34) | 30 (18–42) | 16 (10–22) | 34 (21–46) | 49 (32–64) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 27.70 (17.61–36.57) | 25.91 (16.53–34.11) | 29.33 (17.17–40.83) | 15.17 (9.36–20.37) | 30.91 (18.93–41.70) | 41.10 (26.42–53.85) | |
RR (Lower-Upper) | 1.351 (1.198–1.522) | 1.355 (1.201–1.526) | 1.288 (1.151–1.452) | 1.331 (1.181–1.501) | 1.325 (1.177–1.494) | 1.361 (1.206–1.533) | |
65–69 years | Estimated Attributable Proportion | 23.92% (16-31.98%) | 24.1% (16.19–32.15%) | 20.53% (12.7-28.69%) | 22.86% (14.92–31.01%) | 22.55% (14.61–30.73%) | 24.44% (16.56–32.48%) |
Estimated number of Attributable Cases | 16 (11–21) | 21 (14–28) | 30 (18–41) | 21 (13–28) | 37 (24–51) | 50 (34–66) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 29.52 (19.74–39.46) | 40.08 (26.93–53.47) | 43.50 (26.91–60.80) | 27.67 (18.06–37.54) | 49.09 (31.82–66.91) | 61.58 (41.71–81.83) | |
RR (Lower-Upper) | 1.315 (1.191–1.470) | 1.318 (1.193–1.474) | 1.258 (1.145–1.402) | 1.296 (1.175–1.449) | 1.291 (1.171–1.444) | 1.323 (1.198–1.481) | |
70–74 years | Estimated Attributable Proportion | 21.51% (13.51–29.69%) | 21.67% (13.67–29.78%) | 18.44% (10.57–26.8%) | 20.55% (12.57–28.92%) | 20.26% (12.31–28.64%) | 21.98% (13.98–29.96%) |
Estimated number of Attributable Cases | 22 (14–31) | 24 (15–32) | 25 (14–37) | 14 (8–19) | 29 (18–41) | 37 (24–51) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 50.91 (31.96–70.25) | 50.74 (31.99–69.72) | 54.56 (31.27–79.30) | 29.68 (18.16–41.77) | 67.33 (40.89–95.16) | 83.42 (53.06-113.71) | |
RR (Lower-Upper) | 1.274 (1.156–1.422) | 1.277 (1.158–1.424) | 1.226 (1.118–1.366) | 1.259 (1.144–1.407) | 1.254 (1.140–1.401) | 1.282 (1.163–1.428) | |
75–79 years | Estimated Attributable Proportion | 19.1% (12.4-25.26%) | 19.25% (12.56–25.4%) | 16.3% (9.67–22.62%) | 18.22% (11.53–24.42%) | 17.96% (11.27–24.19%) | 19.53% (12.87–25.67%) |
Estimated number of Attributable Cases | 19 (12–25) | 26 (17–34) | 34 (20–48) | 17 (11–22) | 35 (22–47) | 50 (33–66) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 58.13 (37.73–76.86) | 79.45 (51.84-104.83) | 103.41 (61.35-143.52) | 46.46 (29.40-62.28) | 97.87 (61.43-131.81) | 141.87 (93.53-186.48) | |
RR (Lower-Upper) | 1.236 (1.142–1.338) | 1.238 (1.144–1.340) | 1.195 (1.107–1.292) | 1.223 (1.130–1.323) | 1.219 (1.127–1.319) | 1.243 (1.148–1.345) | |
80–84 years | Estimated Attributable Proportion | 16.6% (10.8-22.27%) | 16.73% (10.94–22.37%) | 14.1% (8.48–20.05%) | 15.81% (10-21.67%) | 15.58% (9.78–21.49%) | 16.98% (11.21–22.57%) |
Estimated number of Attributable Cases | 24 (16–33) | 30 (19–40) | 36 (22–52) | 18 (11–24) | 37 (23–52) | 44 (29–59) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 129.08 (83.99–173.20) | 117.85 (77.07-157.62) | 141.97 (85.35–201.90) | 70.95 (44.88–97.25) | 172.58 (108.35-238.03) | 203.91 (134.65-271.09) | |
RR (Lower-Upper) | 1.199 (1.121–1.287) | 1.201 (1.123–1.288) | 1.164 (1.093–1.251) | 1.188 (1.111–1.277) | 1.185 (1.108–1.274) | 1.205 (1.126–1.292) | |
+ 85 years | Estimated Attributable Proportion | 14.03% (8.99–19.4%) | 16.47% (12.37–21.03%) | 11.91% (6.95–17.28%) | 13.36% (8.32–18.8%) | 13.16% (8.13–18.59%) | 14.35% (9.33–19.72%) |
Estimated number of Attributable Cases | 35 (23–49) | 46 (35–59) | 55 (32–79) | 30 (18–42) | 60 (37–85) | 74 (48–102) | |
Estimated number of Attributable Cases per 100,000 Population at Risk | 250.03 (160.30-345.81) | 241.91 (181.64-308.89) | 255.01 (148.77-370.03) | 122.81 (76.48-172.81) | 303.26 (187.29-428.24) | 396.36 (257.70-544.47) | |
RR (Lower-Upper) | 1.163 (1.099–1.241) | 1.197 (1.141–1.266) | 1.135 (1.075–1.209) | 1.154 (1.091–1.232) | 1.152 (1.088–1.228) | 1.168 (1.103–1.246) | |